ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,277.51
      0.80%
      US Tech 100
      18,064.80
      0.02%
      Dow Jones
      38,686.32
      1.51%
      Brent Oil
      81.295
      0.00%
      Bitcoin
      67,874.11
      0.22%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Canada
      5. TSXV
      6. Cotinga Pharmaceuticals Inc (COT)

      7. Cotinga Pharmaceuticals Inc (COT) News

      COT

      Cotinga Pharmaceuticals (COT)

      Cotinga Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:TSXV:COT
      DateTimeSourceHeadlineSymbolCompany
      10/15/20208:01AMPR Newswire (Canada)Suspension de la négociation par l'OCRCVM - COTTSXV:COTCotinga Pharmaceuticals Inc
      10/15/20207:55AMPR Newswire (Canada)IIROC Trading Halt - COTTSXV:COTCotinga Pharmaceuticals Inc
      11/07/20194:10PMPR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - COTTSXV:COTCotinga Pharmaceuticals Inc
      11/07/20194:09PMPR Newswire (Canada)IIROC Trading Resumption - COTTSXV:COTCotinga Pharmaceuticals Inc
      10/07/20198:13AMPR Newswire (Canada)Suspension de la négociation par l'OCRCVM - COTTSXV:COTCotinga Pharmaceuticals Inc
      10/07/20198:12AMPR Newswire (Canada)IIROC Trading Halt - COTTSXV:COTCotinga Pharmaceuticals Inc
      07/24/20144:20PMMarketwired CanadaCritical Outcome Technologies Reports Year-End Financial and Operating ResultsTSXV:COTCotinga Pharmaceuticals Inc
      06/23/20149:00AMMarketwiredCritical Outcome Technologies Seeks to Redefine Personalized Cancer Care With Project ROSALINDTSXV:COTCotinga Pharmaceuticals Inc
      06/23/20149:00AMMarketwired CanadaCritical Outcome Technologies Seeks to Redefine Personalized Cancer Care With Project ROSALINDTSXV:COTCotinga Pharmaceuticals Inc
      06/17/20149:00AMMarketwiredCritical Outcome Technologies Receives Orphan Drug Designation For COTI-2TSXV:COTCotinga Pharmaceuticals Inc
      06/17/20149:00AMMarketwired CanadaCritical Outcome Technologies Receives Orphan Drug Designation For COTI-2TSXV:COTCotinga Pharmaceuticals Inc
      06/16/20149:00AMMarketwired CanadaCritical Outcome Technologies to Commence Trading in U.S. on OTCQB Under Symbol COTQFTSXV:COTCotinga Pharmaceuticals Inc
      06/16/20149:00AMMarketwiredCritical Outcome Technologies to Commence Trading in U.S. on OTCQB Under Symbol COTQFTSXV:COTCotinga Pharmaceuticals Inc
      06/13/20147:42PMMarketwired CanadaCritical Outcome Technologies Inc.: SeeThruEquity Initiates Research CoverageTSXV:COTCotinga Pharmaceuticals Inc
      06/13/20149:00AMMarketwiredCritical Outcome Technologies Invited to Present at 16th International p53 Workshop in SwedenTSXV:COTCotinga Pharmaceuticals Inc
      06/13/20149:00AMMarketwired CanadaCritical Outcome Technologies Invited to Present at 16th International p53 Workshop in SwedenTSXV:COTCotinga Pharmaceuticals Inc
      06/04/20149:00AMMarketwiredCritical Outcome Technologies Inc. Completes FinancingTSXV:COTCotinga Pharmaceuticals Inc
      06/04/20149:00AMMarketwired CanadaCritical Outcome Technologies Inc. Completes FinancingTSXV:COTCotinga Pharmaceuticals Inc
      05/27/20144:48PMMarketwired CanadaCritical Outcome Technologies Inc. Announces Warrant Term AmendmentTSXV:COTCotinga Pharmaceuticals Inc
      05/27/20144:48PMMarketwiredCritical Outcome Technologies Inc. Announces Warrant Term AmendmentTSXV:COTCotinga Pharmaceuticals Inc
      05/27/20149:00AMMarketwiredCritical Outcome Technologies Selected to Present at Multiple Investor Conferences in New York CityTSXV:COTCotinga Pharmaceuticals Inc
      05/27/20149:00AMMarketwired CanadaCritical Outcome Technologies Selected to Present at Multiple Investor Conferences in New York CityTSXV:COTCotinga Pharmaceuticals Inc
      05/22/20149:00AMAccess WireSeeThruEquity 3rd Annual Microcap Investor Conference To Be Held May 28, 2014TSXV:COTCotinga Pharmaceuticals Inc
      05/01/20148:48AMMarketwiredFinancing Increases Runway to the Clinic for COTI-2, Critical Outcome's Lead Cancer Drug CandidateTSXV:COTCotinga Pharmaceuticals Inc
      05/01/20148:48AMMarketwired CanadaFinancing Increases Runway to the Clinic for COTI-2, Critical Outcome's Lead Cancer Drug CandidateTSXV:COTCotinga Pharmaceuticals Inc
      04/14/20144:30PMMarketwired CanadaCritical Outcome Technologies Announces Warrant IssuanceTSXV:COTCotinga Pharmaceuticals Inc
      04/04/20149:00AMMarketwiredCritical Outcome Technologies Applies for Orphan Drug Designation for COTI-2 Treatment of Ovarian CancerTSXV:COTCotinga Pharmaceuticals Inc
      04/04/20149:00AMMarketwired CanadaCritical Outcome Technologies Applies for Orphan Drug Designation for COTI-2 Treatment of Ovarian CancerTSXV:COTCotinga Pharmaceuticals Inc
      03/14/20149:00AMMarketwiredCritical Outcome Technologies Reports Third Quarter ResultsTSXV:COTCotinga Pharmaceuticals Inc
      03/14/20149:00AMMarketwired CanadaCritical Outcome Technologies Reports Third Quarter ResultsTSXV:COTCotinga Pharmaceuticals Inc
       Showing the most relevant articles for your search:TSXV:COT

      Your Recent History

      NYSE
      CTRI
      Centuri
      Delayed Upgrade Clock